News Articles

Thursday Aug 08, 2024 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments

Lexaria, a global innovator in drug delivery platforms, is exploring alternatives to traditional diabetes and obesity management through its patented DehydraTECH(TM) technology to potentially enhance oral ingestion vs. injection treatment of GLP-1 drugs The company has made significant strides pairing their bioavailability enhancing DehydraTECH with glucagon-like peptide-1 (“GLP-1”) drugs used for treatment of diabetes and obesity Projections are that by 2030 over 54.9 of Americans…

Wednesday Aug 07, 2024 - 9:45 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”

The report explores the growth, competition, and consumer trends, for lesser known cannabinoids The report highlights a 5.4% revenue increase in the edible market for 2023, with total sales reaching $2.097 billion As consumer preferences shift towards edibles for their therapeutic effects and consistent experiences, the industry product landscape is set to evolve With the increasing acceptance of cannabis use in society, the popularity of…

Wednesday Aug 07, 2024 - 9:45 am

FinovateFall New York 2024 Invites the Global Fintech Community

The FinovateFall 2024 event, held from September 9-11, 2024, at the Marriott Marquis Times Square, New York, offers the premiere interactive business platform, for industry experts, startups, and unicorns, to stage demos and showcase innovative ideas. FinovateFall New York will witness 2,000+ attendees interacting with peers and industry leaders on the event floor, with over 1,000 bank and financial institution representatives, and with 1,400+ attendees…

Tuesday Aug 06, 2024 - 9:45 am

Clene Inc. (NASDAQ: CLNN) Advances Neurodegenerative Disease Treatment with Innovative Nanotherapeutics

Clene is developing a new class of drugs that hold the potential to transform the lives of millions suffering from debilitating conditions such as Amyotrophic Lateral Sclerosis (“ALS”), Multiple Sclerosis (“MS”), and Parkinson’s Disease (“PD”) CNM-Au8(R), Clene’s lead drug candidate, is a fundamentally new approach for treating the underlying factors contributing to ALS, MS, and PD, by restoring neuronal health and function ALS, the most…

Tuesday Aug 06, 2024 - 9:00 am

Nightfood Holdings Inc. (NGTF): Capitalizing on the Booming Late-Night Snack Market

The U.S. snack market is predicted to grow to $169.6 billion by 2027 93% of adults regularly snack at night combining for over 1 billion bedtime snacks consumed every week. Unfortunately, the most popular choices are both unhealthy and sleep-disruptive Nightfood, with their newly launched sleep-friendly cookie line, is poised to lead the burgeoning sleep-friendly nighttime snack category Earlier this month, Nightfood Holdings signed a…

Monday Aug 05, 2024 - 10:30 am

DGE 13th Advancing Women’s Leadership in Pharma & Healthcare Conference, Philadelphia

Leaders of the pharma, biotech, and medical device healthcare industry, are invited to attend the 13th Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare from September 23-25, 2024, in Philadelphia, PA. This DGE program will focus on empowering women executives in leadership roles and closing the workplace gender gap. Success stories will be shared by women leaders who have succeeded after facing numerous…

Monday Aug 05, 2024 - 9:45 am

Correlate Energy Corp. (CIPI) Makes Energy Transition an Attainable Option for Climate-conscious Customers

Decentralized energy generation for specific geographic locations is growing in popularity as a solution for customers searching for climate-friendly alternatives Environmentally conscious corporations are likewise seeking solutions that will help them meet global sustainability goals and social and governance reporting Distributed energy solutions developer Correlate Energy Corp. is helping clients meet the challenges of the modern energy era, focusing on behind-the-meter solar infrastructure improvements, access…

Monday Aug 05, 2024 - 9:00 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Reveals Blue Sky Potential at Gochager Lake Property with Mal Lake Similarities

Fathom Nickel’s sprawling Gochager Lake Project covers 22,000+ hectares in the metal rich Trans-Hudson Corridor in Saskatchewan, Canada Located on the west side of the property about 10 kilometers from the Gochager deposit, the Mal Lake tenure hasn’t been explored since 1967; Fathom just re-evaluated available historic drill core The findings suggest similarities in nickel tenor, nickel-to-copper ratio, and even the source magma type between…

Friday Aug 02, 2024 - 2:00 pm

Meta Platforms Inc. (NASDAQ: META) and Its Strategic Focus on AI Technology

Meta Platforms (NASDAQ: META), a leading technology company, has been making headlines with its significant advancements in artificial intelligence (“AI”). The company’s CEO, Mark Zuckerberg, recently announced that Meta’s AI assistant is on track to become the most utilized in the world. This statement underscores the company’s commitment to AI technology and its potential to drive future growth. Meta, known for its social media platforms…

Friday Aug 02, 2024 - 10:30 am

Post-Event Recap: 4th Chief Patient Officer Summit

The 4th Chief Patient Officer Summit held on July 15-16, 2024, was a resounding success, bringing together industry leaders, experts, and stakeholders to discuss and shape the future of patient-centric healthcare. The event featured insightful sessions, interactive panel discussions, and valuable networking opportunities, all aimed at enhancing patient engagement and care. Highlights from the Summit Keynote Sessions: Kay Matthews shared a “Trail Blazer Keynote: Knowledge…

Friday Aug 02, 2024 - 9:45 am

ECGI Holdings Inc. (ECGI) Targeting Significant Opportunity for Growth, Revenue, and Expansion, in Popular Luxury Equestrian Market

ECGI Holdings is a diversified holding company focusing on viticulture, luxury fashion, and equestrian markets The company believes the luxury apparel and accessories segments, which excludes broader categories like watches, jewelry, and beauty, constitute about 50% of the luxury market in the U.S. and possibly globally The luxury apparel and accessories segments are valued at approximately $37 billion in the U.S., which would translate to…

Friday Aug 02, 2024 - 9:00 am

Software Effective Solutions Corp. (SFWJ) Dedicated to Becoming Leader in Growing Cannabis Sector

A recent report projects that the cannabis market, which totaled an estimated $27.7 billion in 2022, will reach $82.3 billion by 2027 The forecast includes businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products MedCana is building technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world With the worldwide cannabis market…

Thursday Aug 01, 2024 - 10:30 am

SuperCom Ltd. (NASDAQ: SPCB) Technology Delivers Needed Solution to World’s Growing Domestic Violence Prevention Concerns

SuperCom Ltd. is an electronic monitoring solutions company working with governments and justice system officials to promote public safety through the secure tracking of suspects and convicted offenders SuperCom has a particular interest in seeing tools in its PureSecurity Suite platform devoted to protecting victims of DV (domestic violence) by tracking offenders and thereby enforcing court-issued protective orders The quality of SuperCom’s technology and related…

Thursday Aug 01, 2024 - 9:45 am

SenesTech Inc. (NASDAQ: SNES) Providing Non-Lethal Rodent Pest Management Solutions Amid Growing Conversation About Unintended Bird Deaths

A study published in 2020 showed that 100% of Red-tailed Hawks that were admitted to the Tufts Wildlife Clinic tested positive for the presence of rodenticides Given how rodents remain a crucial food source for birds of prey, anticoagulant rat poison is threatening these populations SenesTech, a rodent fertility control product provider, and the inventor of the only EPA-registered contraceptive for male and female rats,…

Thursday Aug 01, 2024 - 9:00 am

Correlate Energy Corp. (CIPI) Making Solar Energy Affordable and Accessible by Making the Process Easy and Seamless

Correlate Energy, a publicly traded distributed energy solutions company, has made clean energy adoption as easy and as seamless as possible for the worldwide business community Doing so has allowed it to make a name for itself and carve out a decent market share in the growing renewable energy space With the global solar capacity set to reach 5.1 TW by 2028, Correlate is positioning…

Wednesday Jul 31, 2024 - 11:15 am

Canada Crypto Week Set For Aug 11-17, 2024: Anchor Event Blockchain Futurist Conference Hosts Multiple Sub-Events Onsite

Toronto, July 22, 2024 – Canada Crypto Week, a week-long series of Web3 and AI events, is set to take place from August 11-17, 2024 in Toronto, Canada. Blockchain Futurist Conference serves as the anchor event for Canada Crypto Week, providing a central hub for the majority of the week’s activities. Many of the 20+ events during Canada Crypto Week will take place onsite at…

Wednesday Jul 31, 2024 - 10:30 am

FinovateFall To Host The Premier Fintech Community In New York

FinovateFall 2024 invites investors, insurers, directors, and C-level executives from banks, for two days of networking, discussions, and a fintech showcase at the prestigious Marriott Marquis Times Square, New York. Finovate has been serving the fintech fraternity for over 15 years, spotlighting fintech companies from startups to veterans on a robust networking platform where they can discuss and demo innovative business strategies. Discover and explore…

Wednesday Jul 31, 2024 - 9:45 am

Software Effective Solutions Corp. (SFWJ) Takes Critical Steps Toward Achieving Global Production and Processing Vision

MedCana has identified Colombia’s Antioquia Valley as a perfect location to begin its initial rollout of technology and production The company is working with five subsidiaries in the area, each of which has three licenses to produce, process and export cannabis Equally important to MedCana is working closely with the people of the Antioquia Valley and maintaining its commitments to its investors Cannabis legalization is…

Wednesday Jul 31, 2024 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Produces Notable Findings in Latest Weight Loss Study

Lexaria, a global innovator in drug delivery platforms, has released interim results from its WEIGHT-A24-1 animal study The study sought to explore the impact of its patented DehydraTECH technology on glucagon-like peptide-1 (“GLP-1”) drugs for the potential treatment of diabetes and weight loss, representing a major global market The first 28 days of dosing yielded positive results that Lexaria’s management described as “noteworthy” It also…

Tuesday Jul 30, 2024 - 11:15 am

Canada’s Mining Legacy Continues: Torr Metals Inc. (TSX.V: TMET) and Quesnel Terrane Hold Promise for New Discoveries

In 2022, Canadian mines produced 510,782 tonnes of copper in concentrate, with over half originating from British Columbia The Quesnel Terrane, which is home to Torr Metals’ expansive Kolos Copper-Gold Project, has the potential to be instrumental in Canada’s next great copper discoveries Torr’s recent rock sampling confirmed copper porphyry mineralization in outcrop adjacent to Highway 5 in the heart of the southern Quesnel Terrane,…

Tuesday Jul 30, 2024 - 10:30 am

Correlate Energy Corp. (CIPI) Building Toward NYSE Uplist as it Meets Opportunities of Decentralized Energy Trend

Distributed energy solutions developer Correlate Energy Corp. helps clients find an affordable way to step up their energy use infrastructure through retrofit upgrades, taking advantage of a variety of financial incentives Decentralized energy generation has been trending as groups throughout the country search for ways to reduce carbon emissions and secure their power supply amid utility outages Correlate’s success is evident in its growing list…

Tuesday Jul 30, 2024 - 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Announces FDA Approval to Transition to New Form of Buntanetap for Future Clinical Trials

Annovis announced in June 2024 that they had filed a composition of matter patent for their new crystal form of buntanetap, along with a provisional patent for the manufacturing process The company’s goal is to use this technology to restore brain function and improve the quality of life for patients dealing with neurodegenerative disease such as Alzheimer’s disease The worldwide market for Alzheimer's disease modifying…

Tuesday Jul 30, 2024 - 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) EM Technology Highly Competitive in Expanding Field of Court-administered Offender Monitoring

Cost-effective and recidivism-reducing alternatives to incarceration continue to occupy a priority for criminal justice systems worldwide as societies grapple with balancing concerns ranging from minimizing threats to sustaining positive work and family environments During the past four decades, electronic monitoring has emerged as a way to help individuals continue functioning positively within their communities after they have been convicted of criminal behavior Israel-based SuperCom Ltd.…

Monday Jul 29, 2024 - 9:45 am

2025 Life Sciences Conference Calendar Announced: Premier Conferences for Industry Professionals

The life sciences sector is set to experience a year of innovation, collaboration, and breakthrough discoveries with the announcement of DGE’s 2025 Life Sciences Conference Calendar. Industry professionals, researchers and key stakeholders will have the opportunity to attend a series of events designed to foster knowledge exchange, showcase cutting-edge research, and facilitate networking among peers. View the full calendar now. 5th Risk-Based Quality Management Summit:…

Monday Jul 29, 2024 - 9:00 am

ECGI Holdings Inc. (ECGI) Strategically Aligning Operations to Harness Opportunities in Burgeoning Global Equestrian and Luxury Markets

ECGI Holdings is making strategic moves to capitalize on the projected growth in various markets, including the global equestrian apparel market, equestrian equipment and tack market, and the greater overall equestrian market The company recently announced the planned launch of a new line of equestrian apparel under Pacific Saddlery’s Allon brand This new collection is intended to elevate the standard of equestrian apparel and will…

Friday Jul 26, 2024 - 9:00 am

Clene Inc. (NASDAQ: CLNN) Discusses Important Developments of CNM-Au8(R) and Its Novel Technology During Xtalks Podcast

Clene's mission is to transform the treatment of neurodegenerative diseases with a new class of drugs, potentially impacting the lives of millions The company’s uniquely structured gold nanocrystals have the remarkable ability to convert critical energetic metabolites in living cells for the production of ATP, the essential energy currency for cellular functions, offering disease combatting capabilities Clene is currently preparing for Phase 3 clinical trials…

Thursday Jul 25, 2024 - 9:45 am

Nightfood Holdings Inc. (NGTF) Eyes Growth with CarryOut Acquisition

Nightfood made its name in the sleep-friendly snack market, but has made two acquisitions diversifying operations recently to capitalize on an emerging market and a reemerging company Nightfood signed an LOI to acquire SWC Group, d/b/a Carryoutsupplies.com Carryoutsupplies.com has serviced over 7,000 wholesale accounts since inception in 2004, but faced extreme challenges in the face of the global covid pandemic Business is returning, presenting an…

Thursday Jul 25, 2024 - 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders

PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration for suramin to treat Human African Trypanosomiasis On June 27th, PaxMedica will have a Type C meeting with the FDA, pivotal for the progress of PAX-101, their leading drug candidate for autism treatment, within the regulatory framework The outcomes of this FDA meeting are crucial, representing a key moment…

Wednesday Jul 24, 2024 - 9:45 am

SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) – Offering Sustainable and Humane Solution to NYC’s Rat Problem

New York City has received lots of backlash, mainly from People for the Ethical Treatment of Animals (“PETA”), for its approach to addressing its rat problem Its approach, so far, has been characterized by the use of traps, poisons, and its “Trash Revolution” program, all of which have been unsustainable SenesTech, a rodent fertility control product provider, through its flagship Evolve(TM) product, offers an alternative…

Wednesday Jul 24, 2024 - 9:00 am

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration

Age-related macular degeneration is a disease significantly impacting the quality of life, making it difficult for individuals to perform everyday activities such as reading, driving, and recognizing faces InMed is currently developing a pipeline of drugs, like INM-089, to treat diseases with a high unmet medical need Delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement in in vivo preclinical disease model Age-related macular degeneration (“AMD”)…

Tuesday Jul 23, 2024 - 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

The new executive team includes Mark White, Alexander Morin, Hilda Maibach, and Blake Jensen These additions are pivotal as the company makes strides toward bringing flagship drug candidate buntanetap closer to New Drug Application (“NDA”) status and to market Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease…

Tuesday Jul 23, 2024 - 9:00 am

Clene Inc. (NASDAQ: CLNN) Presents Updates on CNM-Au8(R) at Emerging Growth Conference 73 – Biotech Feature

CNM-Au8(R) works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health Clene has conducted several clinical trials to evaluate the safety and efficacy of CNM-Au8 in neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) The global ALS treatment market is expected to grow significantly, driven by the increasing prevalence of the disease among the aging population Clene has submitted a briefing…

Monday Jul 22, 2024 - 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Validate Earlier Semaglutide Studies with Successful GLP-1-H24-2 Study Dosing

Lexaria, a global innovator in drug delivery platforms, recently completed dosing of its human pilot study #2, GLP-1-H24-2 The study is to explore the tolerability, side effects, and blood levels of semaglutide, a glucagon-like peptide-1 (“GLP-1”) drug For Lexaria, the results from this study look to validate earlier studies that have demonstrated improvements in the delivery of semaglutide into the bloodstream Results from the GLP-1-H24-2…

Monday Jul 22, 2024 - 9:45 am

ECGI Holdings Inc. (ECGI) Makes ‘Bold Step Forward’ with Appointment of AI and ML Expert to Board of Advisors

ECGI Holdings, a diversified holding company with a unique portfolio encompassing viticulture, luxury fashion, and hospitality, recently appointed Mandeep Singh, an AI and machine learning expert, to its Board of Advisors Singh’s addition is part of the company’s preparations for the launch of a new line of apparel under Pacific Saddlery’s Allon brand AI provides confidence in size selection, minimizing returns, and better measurement for…

Monday Jul 22, 2024 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Adds Second Annealing Quantum Computer in the U.S. and Unveils New Hybrid Quantum Solver

D-Wave introduced its new hybrid quantum solver designed to tackle previously intractable workforce, manufacturing, and logistics optimization problems at its Qubits 2024 conference The new hybrid solver is expected to have a positive impact on a variety of business processes, particularly in workforce, manufacturing, and logistics optimization D-Wave is also deploying a second U.S.-based Advantage(TM) quantum computer at Davidson Technologies’ global headquarters, accessible to D-Wave…

Friday Jul 19, 2024 - 9:45 am

SuperCom Ltd.’s (NASDAQ: SPCB) Latest $2.9 Million Government EM Contract Shows Continuing Appeal of its Technology

Electronic monitoring (“EM”) technology developer SuperCom Ltd. recently reported a new contract with European government clients for its flagship product, its third such contract secured within a three-month period SuperCom’s business with European governments that are seeking its EM technology solutions amounts to over $11 million in new orders since April SuperCom’s flagship EM PureSecurity Suite products provide monitoring solutions that are chiefly being used…

Friday Jul 19, 2024 - 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Announces New Data From Phase III Study of Buntanetap for Early Parkinson’s Disease

The study shows buntanetap is effective in enhancing both motor and cognitive functions, as well as non-motor activities in Parkinson’s Disease patients Following the announcement of these positive results, the company’s stock price surged by 76% The data revealed that while 12% of Parkinson’s Disease patients showed cognitive decline, buntanetap not only halted this decline but also led to improvements Annovis held a webcast to…

Thursday Jul 18, 2024 - 10:30 am

Nickel Rush Heats Up in Canada: Opening Doors for Companies Like Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) as Canada Eyes a Top Spot Among Global Producers

Nickel demand is expected to grow at a continually accelerating rate over the coming years and decades By 2040, use in batteries will command 41% of total nickel usage, up from just 7% in 2021 Nickel is considered one of the most strategically vulnerable critical metals in North America or the west Like Canada’s Critical Minerals Infrastructure Fund (“CMIF”), the west has been making increasing…

Thursday Jul 18, 2024 - 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction

Clene plans to submit a briefing book to the U.S. Food and Drug Administration by July 13 as Part of Overall Process to Support Approval for CNM-Au8(R) for Treatment of ALS Type C interaction is aimed at obtaining FDA feedback on the potential pathway for a new drug application for CNM-Au8 as a treatment for ALS via the accelerated approval process The briefing book includes…

Thursday Jul 18, 2024 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Reveals Findings of Hyperion Research Quantum Optimization ROI Study and Announces Nomination for Technology Impact Awards

Majority of surveyed businesses actively engaged in quantum computing anticipate significant returns on investment (“ROI”) from their quantum optimization efforts Survey also highlights a significant increase in quantum adoption, with 21% of respondents either currently employing or planning to integrate quantum technology into production within the next 12 to 18 months D-Wave has been named a finalist in the GameChanger Ambition category of the upcoming…

Articles

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions